Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» omaveloxolone
omaveloxolone
FDA scraps AdComm for Reata's rare disease candidate, leaving analysts squinting at the tea leaves
Fierce Biotech
Sun, 10/16/22 - 05:17 pm
Reata Pharmaceuticals
omaveloxolone
FDA
Friedreich's Ataxia
Reata’s ‘regulatory concerns’ turn into three-month delay on FDA decision for Friedreich’s ataxia drug
Endpoints
Tue, 08/9/22 - 10:27 am
Reata Pharmaceuticals
Friedreich's Ataxia
FDA
omaveloxolone
Reata Pharmaceuticals Sees Hiccup in Filing for Approval of FA Drug
BioSpace
Wed, 08/12/20 - 12:11 am
Reata Pharmaceuticals
Friedreich's Ataxia
omaveloxolone
Reata Pharmaceuticals Just Raised $505 Million to Treat Orphan Diseases
Motley Fool
Tue, 11/26/19 - 10:29 am
Reata Pharmaceuticals
orphan diseases
omaveloxolone
Reata shocks analysts with pivotal win in Friedreich's ataxia
Fierce Biotech
Tue, 10/15/19 - 10:18 am
Reata Pharmaceuticals
omaveloxolone
Friedreich's Ataxia
clinical trials
Reata gets another shot in Friedreich’s ataxia
EP Vantage
Wed, 08/7/19 - 10:50 am
Reata Pharmaceuticals
omaveloxolone
Friedreich's Ataxia
